Literature DB >> 20452618

Thromboresistant cardiopulmonary bypass circuits: room for improvement?

Jeffrey A Poynter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20452618      PMCID： PMC2920367          DOI： 10.1016/j.jss.2010.02.032

Source DB:  PubMed          Journal:  J Surg Res        ISSN： 0022-4804            Impact factor:   2.192


× No keyword cloud information.
  6 in total

1.  Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.

Authors:  J Borowiec; S Thelin; L Bagge; L Nilsson; P Venge; H E Hansson
Journal:  J Thorac Cardiovasc Surg       Date:  1992-09       Impact factor: 5.209

2.  Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population.

Authors:  V Videm; T E Mollnes; E Fosse; B Mohr; K Bergh; T A Hagve; A O Aasen; J L Svennevig
Journal:  J Thorac Cardiovasc Surg       Date:  1999-04       Impact factor: 5.209

3.  Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass.

Authors:  E Fosse; O Moen; E Johnson; G Semb; V Brockmeier; T E Mollnes; M K Fagerhol; P Venge
Journal:  Ann Thorac Surg       Date:  1994-08       Impact factor: 4.330

4.  Multifactorial comparison of modified and conventional perfusion strategies in a porcine model of cardiopulmonary bypass.

Authors:  Bader E Hussaini; Patrick R Treanor; Nancy A Healey; Xiu-Gui Lu; Shukri F Khuri; Hemant S Thatte
Journal:  J Surg Res       Date:  2010-02-16       Impact factor: 2.192

5.  Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery.

Authors:  C Olsson; A Siegbahn; A Henze; B Nilsson; P Venge; P O Joachimsson; S Thelin
Journal:  Scand Cardiovasc J       Date:  2000       Impact factor: 1.589

6.  Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial.

Authors:  M Ranucci; A Mazzucco; R Pessotto; G Grillone; V Casati; L Porreca; R Maugeri; M Meli; P Magagna; S Cirri; P Giomarelli; R Lorusso; A de Jong
Journal:  Ann Thorac Surg       Date:  1999-04       Impact factor: 4.330
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.